FDA Unwilling To Change View On Dangers Of Zicam

Law360, New York (October 26, 2009, 1:41 PM EDT) -- The maker of Zicam, a cold medication that has come under fire in recent months for its potential danger to consumers, has said in a regulatory filing that the U.S. Food and Drug Administration is unwilling to reverse its stance that the medication could cause users to lose their sense of smell.

Matrixx Initiatives Inc., which makes Zicam, disclosed in an 8K filing with the U.S. Securities and Exchange Commission Monday that the FDA was unlikely to change the position it took in a warning letter...
To view the full article, register now.